Figure 1.
Two head and neck squamous cell carcinoma samples (A, D, haematoxylin and eosin) analysed with the 22C3 PharmDx assay (B, E) and the SP263 assay (C, F). Programmed death‐ligand 1 expression as determined with the 22C3 and SP263 antibodies shows similar combined positive score (CPS) values in the two cases (A–C, CPS ≥ 20; D–F, CPS < 20).